The top medicine technology of this weekImproving Quality, Cost-Effectiveness, and Time Savings in Preclinical Inhalable Formulation Development
11/18/2009
| PITTSBURGH, Nov. 18 /- In today's fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year's Drug Delivery to the Lungs 20 (DDL 20) meeting, experts from ChemImage Corporation, will be on hand to discuss our patented chemical imaging technology a... [Comments] |
Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
11/18/2009
| PORTON DOWN, England, Nov. 18 /- Enigma Diagnostics Limited, the decentralised point-of-care molecular diagnostics company, announces the showcasing of its fully automated Point-of-Care mini-laboratory instrument, the Enigma ML, at MEDICA 2009 at the Dusseldorf Trade Fair Centrehas in Dusseldorf, Germany in Hall 1, stand E07a between 18-20 November. The Enigma... [Comments] |
New Study Heralds Use of Blood Biomarkers to Predict Preeclampsia
11/17/2009
| NEW YORK, November 17 /- A new study that examines the valueof maternal blood biomarkers will help identify and monitor patients at riskof developing preeclampsia and is set to change the way expectant mothers arecared for in prenatal clinics around the world. The study, conducted by scientists at the highly-respected NationalInstitute of Child and Hum... [Comments] |
Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace
11/24/2009
| RALEIGH,N.C.,Nov.24/PRNewswire/--PharmaceuticalInstitute,aleadingproviderofspecializedtrainingsolutionsforthepharmaceuticalandbiotechindustry,todayannouncedthelaunchofanewe-coursetitled, HospitalMarketplace .Thenew HospitalMarketplace e-courseisthenewestadditiontothecompany's ManagedMarketsExcellence(TM) series,acomprehensiveseriesofe-coursesdesignedtofillthecriticalneedforbasicandadvanc... [Comments] |
SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts
11/24/2009
| HOLMDEL,N.J.,Nov.24/PRNewswire/--SpartaSystems,Inc.,themakerofTrackWisesoftwareandthemarketleaderinenterprisequalityandcompliancesolutions,todayannouncedthatSSLInternationalplc,arapidlyexpandingconsumerproductcompanyandtheparentcompanyforgloballyrecognizedbrandssuchasDurexandScholl,hasgonelivewithTrackWiseEnterpriseQualityManagementSystem(EQMS).ThecompanyisnowleveragingtheTrackWisesystem... [Comments] |
Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ
11/24/2009
| SALTLAKECITY,Nov.24/PRNewswire/-- InfiniteMind ,aSaltLakeCitybasedsoftwarecompany,announcesthelaunchofanewonlinevisiontherapyprogrameyeQ,thesoftwareprogramistobeusedinconjunctionwithexistingin-officetherapymethods. eyeQ wasintroducedattheCOVDconferencethisOctoberinColorado.Currentindustrypresidentelect,Dr.BradHabermehlbelievesthe eyeQ programaddssignificantvaluetohispractice,Senso... [Comments] |
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
11/24/2009
| SANDIEGO,Nov.24/PRNewswire/--AmbitBiosciencesCorporationannouncedtodaythattherewillbemultiplepresentationsevaluatingAC220,anovelsecondgenerationFLT3inhibitor,inAMLatthe51stAmericanSocietyofHematologyAnnualMeeting(ASH)tobeheldinNewOrleans,LA,December5-8,2009.AnoralpresentationwillhighlightresultsfromanongoingclinicalPhaseImonotherapysafetystudyinadultswithacutemyeloidleukemia(AML).Additio... [Comments] |
New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS
11/24/2009
| WASHINGTON,Nov.24--America'spharmaceuticalresearchandbiotechnologycompaniesaretesting97medicinesandvaccinestotreatorpreventHIV/AIDSandrelatedconditions,accordingtoanewreportreleasedtodaybythePharmaceuticalResearchandManufacturersofAmerica(PhRMA).December1marksthe21stanniversaryof"WorldAIDSDay"-aglobalawarenesscampaignthatoriginatedatthe1988WorldSummitofMinistersofH... [Comments] |
CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
11/24/2009
| MISSISSAUGA,Ontario,Nov.24FirstCall/--CardioGenicsHoldingsInc.(OTCBulletinBoard:CGNH),adeveloperoftechnologyandproductstargetingtheimmunoassaysegmentoftheIVDtestingmarket,reportsthatMerckChimieS.A.S.("MerckChimie")isprogressingtothenextphaseofthecommercializationofCardioGenics'proprietarysilvercoatedparamagneticBeads("Beads"). PertheagreementwithMerckChimiethatwasexecut... [Comments] |
Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
11/24/2009
| XI'AN,China,Nov.24Asia/--HuifengBio-PharmaceuticalTechnology,Inc.(OTCBulletinBoard:HFGB),aleadingdeveloperandproducerofplantextractsandpharmaceuticalrawmaterialsforuseinpharmaceutical,nutraceuticalandfoodproductioninXi'an,China,todayreportedthatinitsthirdquarter,thecompanyrealizeda26%increaseinrevenues. RevenuesforthequarterendedSept.30,2009were$4,465,770,anincreas... [Comments] |